RTsafe to serve as exhibitor sponsor of War On Cancer Europe 2019 summit held by The Economist
RTsafe today announced that it will serve as exhibitor sponsor of the War On Cancer Europe 2019 summit held by The Economist. The summit will take place on Tuesday, November 26th in London. In addition, RTsafe’s Founder and Chief Scientific Officer, Dr. Evangelos Pappas, will participate in a panel discussion on Personalized Cancer Care which will take place at 2:30pm on the same day. The panel session will address initiatives for personalised healthcare and precision medicine.
RTsafe will also be exhibiting at its booth its Personalized PseudoPatient™ technology which recently earned a 2019 R&D Award by R&D World Magazine as one of the 100 most technologically significant products of the past year. This 510(k) FDA Approved technology enables radiotherapy professionals to test every radiotherapy procedure on an anatomically perfect replica of the patient’s head before the actual treatment is performed.
The Economist Event’s series of cancer summits in Europe articulate the challenges and opportunities in improving cancer control. There is still considerable unmet patient and societal need; cancer control and preparedness varies among and within countries; and investment and health systems generally lag behind the advances in technology and services available to combat cancer. This year’s summit will look to solutions, not problems. The event gathers global influencers, government ministers, private-sector CEOs, academics, and healthcare professionals from Europe.
RTsafe is a medical technology company that has developed a unique approach to quality assurance that significantly enhances the safety and accuracy of radiotherapy for cancer and other medical conditions. It combines proven expertise in medical physics with highly accurate 3D printing technology to create pseudo‐in‐vivo dosimetry phantoms towards End‐to‐End commissioning, benchmarking and patient‐specific quality assurance in SRS, IMRT, VMAT and SBRT applications. The anatomically accurate effigies enable medical professionals to plan more precise treatment interventions for each individual patient and help radiotherapy technology innovators to fine‐tune their products. The result is more effective individualized therapy and reduced patient risk. For more information, visit www.rt-safe.com.